Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Axial Therapeutics Expands Clinical Development Capabilities with Key Appointments
11 oct. 2022 08h00 HE
|
Axial Therapeutics
- Clinical development operations focused on ongoing Phase 2b clinical trial of AB-2004 in autism; data anticipated in 2023 - - Team also supporting additional microbiome-based small molecule...
Axial Therapeutics to Present at BioJapan Conference
06 oct. 2022 08h00 HE
|
Axial Therapeutics
WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
Microbiome Therapeutics Global Market Report 2022: Increasing R&D By Major Players Creates Lucrative Opportunities
04 oct. 2022 05h13 HE
|
Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global microbiome therapeutics...
Microbiome Therapeutics Market Report 2022: Success Rate in C. Difficile Infection Driving Adoption
19 sept. 2022 07h38 HE
|
Research and Markets
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Market Size, Share & Trends Analysis Report by Type (FMT, Microbiome Drugs), by Application (C. difficile, Crohn's...
Global Microbiome Sequencing Services Market Report 2022: Demand for Early Disease Detection and Diagnosis Fuels 20.09% Annual Growth
12 sept. 2022 08h43 HE
|
Research and Markets
Dublin, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Microbiome Global Market Report 2022: Increased Need for Immunology, Increasing Collaborations, Government Initiatives, Increased Healthcare Expenditure All Driving Growth
06 sept. 2022 04h53 HE
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering.The global microbiome...
Microbiome Global Market Report 2022: Increasing Prevalence of Inflammatory Bowel Disease Fueling Sector Growth
31 août 2022 04h33 HE
|
Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2022, Type, Application, Technology" report has been added to ResearchAndMarkets.com's offering. The global...
Microbiome Partnering Terms and Agreements Report 2022: The Leading & Most Active Microbiome Dealmakers Since 2010
18 août 2022 06h43 HE
|
Research and Markets
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Microbiome...
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
15 août 2022 23h41 HE
|
Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
11 août 2022 08h00 HE
|
Summit Therapeutics Inc.
Menlo Park, California, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...